Compare ARMP & SPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ARMP | SPT |
|---|---|---|
| Founded | N/A | 2010 |
| Country | United States | United States |
| Employees | 61 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 295.5M | 327.6M |
| IPO Year | 1996 | 2019 |
| Metric | ARMP | SPT |
|---|---|---|
| Price | $8.06 | $6.21 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 8 |
| Target Price | ★ $15.00 | $11.75 |
| AVG Volume (30 Days) | 73.3K | ★ 1.5M |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 32.11 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $457,547,000.00 |
| Revenue This Year | N/A | $8.86 |
| Revenue Next Year | N/A | $8.04 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 12.72 |
| 52 Week Low | $1.74 | $4.92 |
| 52 Week High | $14.98 | $23.05 |
| Indicator | ARMP | SPT |
|---|---|---|
| Relative Strength Index (RSI) | 37.57 | 49.92 |
| Support Level | $7.43 | $6.03 |
| Resistance Level | $12.11 | $7.45 |
| Average True Range (ATR) | 1.12 | 0.43 |
| MACD | -0.22 | -0.03 |
| Stochastic Oscillator | 14.20 | 26.65 |
Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology. It has completed three Phase 2 clinical trials to date. The Company operates and manages its business as one reportable operating segment, which is the business of developing pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat acute and chronic bacterial infections using its proprietary bacteriophage-based technology.
Sprout Social Inc develops a cloud software that brings together social messaging, data and workflows in a unified system of record, intelligence, and action. It has a centralized, secure and powerful platform that can scale horizontally across an organization to drive maximum business value. The firm generates majority revenue from software subscriptions. Geographically, the company operates in Americas, EMEA, and Asia Pacific, of which it derives maximum revenue from Americas.